NuScale Power Corporation (SMR) Stock Analysis
Is SMR a good investment?
NuScale Power Corporation (SMR) has a Plutrex AI rating of 42.0/100 as of August 22, 2026, indicating a Sell consensus. The stock is halal-compliant per AAOIFI standards. Key strength: $1.07B cash position with zero debt (D/E: 0.0x vs. industry 2.17x) provides ~5.2 years of runway at -$204.6M FCF/year — the strongest balance sheet in the peer group with no refinancing risk or covenant constraints. Main concern: Q2 revenue of $75,000 (down -99.1% YoY) with next-year EPS growth of -31.3% confirms losses will deepen before any recovery — the $750M share sale announced alongside these results signals management expects continued cash burn and creates near-term dilution overhang that suppresses the stock.
Investment Summary
NuScale Power (SMR) remains a high-risk, long-duration speculative bet on nuclear small modular reactor (SMR) commercialization. At $9.40/share, the stock is essentially unchanged from last week's $9.39 close, and the investment thesis is equally unchanged. The company is effectively pre-revenue — Q2 revenue collapsed to $75,000 (yes, seventy-five thousand dollars), producing an operating margin of -85,337% and net margin of -3,888.7%. The P/E and PEG ratios are incalculable due to negative earnings. The sole valuation anchor is P/B of 1.81x against a $1.07B cash position. The bull case rests entirely on the 5-year forward EPS growth projection of 40.3% (148% above the industry average of 16.2%) and a potential TVA deal described by the CEO as 6-8 gigawatts. The bear case is immediate: next-year EPS growth of -31.3% means losses deepen before any recovery, and the $750M share sale announced alongside Q2 results signals ongoing dilution risk. Analyst consensus target of $12.59 implies 33.9% upside from current price, but this target has drifted lower from $12.90 to $12.59 over the past two weeks. The stock is trading within the speculative entry zone ($8.50-$9.50) established in prior analysis, but nothing has materially improved to upgrade conviction.
Key Strengths
- $1.07B cash position with zero debt (D/E: 0.0x vs. industry 2.17x) provides ~5.2 years of runway at -$204.6M FCF/year — the strongest balance sheet in the peer group with no refinancing risk or covenant constraints
- 5-Year forward EPS growth projection of 40.3% is 148% above the industry average of 16.2%, making SMR a projected sector growth leader IF commercialization milestones are achieved — the TVA deal (6-8 GW per CEO) and graphite supply agreements represent tangible progress toward this thesis
- Analyst consensus target of $12.59 implies 33.9% upside from $9.40, and the potential TVA deal plus AI data center power demand narrative provide identifiable catalysts that could close this gap over a 12-24 month horizon
Key Concerns
- Q2 revenue of $75,000 (down -99.1% YoY) with next-year EPS growth of -31.3% confirms losses will deepen before any recovery — the $750M share sale announced alongside these results signals management expects continued cash burn and creates near-term dilution overhang that suppresses the stock
- Stock has declined from $15 reference price to $9.40 (a -37.3% drawdown per the '52-Week High' headline), analyst target has drifted from $12.90 to $12.59 over two weeks, and technical momentum remains deeply negative — the market is not rewarding positive narrative (TVA deal, graphite supply) with price appreciation, suggesting persistent institutional skepticism about execution timeline
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
SMR's fundamentals are structurally impaired at every level below gross margin. Gross margin of 16.0% (vs. industry 27.49%) is the only positive profitability metric, and it is 41.7% below peers. Operating margin of -85,337% (vs. industry -10,050%) is 749% worse than already-distressed peers — a direct consequence of Q2 revenue of $75,000 against a full operating cost structure. Net margin of -3,888.7% (vs. industry -390.6%) is 896% worse than peers. ROE of -30.2% (vs. industry -40.1%) is the one relative bright spot — SMR destroys book value 24.7% more slowly than peers, supported by its $1.07B cash cushion. Free cash flow of -$204.6M annually provides approximately 5.2 years of runway at current burn, but the $750M share sale (dilutive) announced in Q2 suggests management is building buffer against commercialization delays. Debt-to-equity of 0.0x vs. industry 2.17x is the strongest balance sheet differentiator in the peer group. Revenue growth of -99.1% YoY (vs. industry +4.51%) reflects the near-total collapse of prior revenue streams — the company is effectively pre-revenue. Next-year EPS growth of -31.3% (vs. industry +56.0%) confirms losses widen before any recovery. The 5-year EPS growth projection of 40.3% (vs. industry 16.2%) is the singular long-term differentiator that prevents this from being a pure sell.
News Sentiment
NuScale Power is fighting to convince investors that its nuclear future is worth waiting for — even as its present looks increasingly bleak. The company's latest quarterly results were stunning in the worst way: revenue collapsed to just $75,000 for the quarter, a 99% drop that left Wall Street speechless. To put that in perspective, that's less than what a single mid-level engineer earns in a year. Alongside those results, NuScale announced a $750 million share sale — essentially asking investors to fund the company while it figures out how to make money. The stock, which once traded near $15, has lost roughly 37% of its value and now sits around $9.40, according to a headline noting that '$10,000 invested at the 52-week high is worth about $1,650 today.' But here's where the story gets complicated. NuScale's CEO is talking about a potential deal with the Tennessee Valley Authority for 6 to 8 gigawatts of nuclear capacity — a contract that would be transformational if it closes. The company has also secured graphite supply agreements, a critical building block for its reactor technology. And analysts are exploring whether industrial heat applications could unlock an entirely new revenue stream. The bottom line: NuScale is a company with a potentially revolutionary technology, a billion-dollar cash cushion, and almost no revenue. For patient investors with a 3-5 year horizon and a high tolerance for uncertainty, the entry zone around $8.50-$9.50 offers speculative upside. For everyone else, this remains a wait-and-see story.
Risk Assessment
PRIMARY RISK: Commercialization delay beyond the 5-year runway. At -$204.6M FCF/year with $1.07B cash, the company has until approximately 2030 before needing additional capital. The $750M share sale extends this runway but confirms dilution is ongoing. If the TVA deal (6-8 GW) fails to materialize or is delayed, the stock could re-test book value (~$5.20/share based on P/B of 1.81x at $9.40). SECONDARY RISK: Continued analyst target erosion ($12.90 → $12.63 → $12.59 over two weeks) suggests the sell-side is gradually reducing expectations. TERTIARY RISK: The options market showing elevated activity may signal informed investors positioning for a binary catalyst — this cuts both ways. MITIGATION: Position size capped at 2% of portfolio. Stop-loss at $7.20 (20% below $9.00 entry midpoint) limits downside to approximately 1.4x book value. Do not add to position above $9.50. The risk/reward at entry midpoint of $9.00: Risk = $1.80 (to stop at $7.20), Reward to T1 = $3.59 (to $12.59), R/R = 2.0x. Reward to T2 = $5.39 (to $14.39), R/R = 3.0x.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is SMR a halal stock?
Yes, NuScale Power Corporation (SMR) is halal-compliant per AAOIFI standards as of the latest quarterly review.
What is Plutrex's AI rating for SMR?
NuScale Power Corporation (SMR) has a Plutrex AI rating of 42.0/100 with a Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is SMR a good investment?
According to Plutrex AI, SMR has a Sell rating (42.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in SMR?
US stocks like SMR can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in SMR?
Plutrex AI identifies the main risks for SMR by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.